Teleflex (manufacturer: Vascular SOLUTIONS) D-Stat Flowable Hemostat, REF 4000; for sealing resid...

FDA Device Recall #Z-1611-2023 — Class II — April 12, 2023

Recall Summary

Recall Number Z-1611-2023
Classification Class II — Moderate risk
Date Initiated April 12, 2023
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm TELEFLEX LLC
Location Morrisville, NC
Product Type Devices
Quantity 1140 units

Product Description

Teleflex (manufacturer: Vascular SOLUTIONS) D-Stat Flowable Hemostat, REF 4000; for sealing residual oozing of tissue tracts of femoral access sites that have been previously closed by suture/collagen-based hemostatic devices.

Reason for Recall

The product contains an expired diluent vial. If the impacted product is used, the sterility of the diluent component cannot be assured as it has passed beyond the studied shelf life of the product.

Distribution Pattern

US Nationwide

Lot / Code Information

UDI/DI M20640000, Lot Numbers: 717535, exp. 04/27/2023; 717413, exp. 04/25/2023

Other Recalls from TELEFLEX LLC

Recall # Classification Product Date
Z-1834-2023 Class I Slick Set Cuffed Endotracheal Tube and Stylet S... May 25, 2023
Z-1875-2023 Class I Endotracheal Tube oral/nasal uncuffed/plain - M... May 25, 2023
Z-1937-2023 Class I Endotracheal Tube oral/nasal uncuffed/plain - M... May 25, 2023
Z-1889-2023 Class I Endotracheal Tube oral/nasal Murphy Eye, High V... May 25, 2023
Z-1905-2023 Class I Slick Set Uncuffed Endotracheal Tube and Stylet... May 25, 2023

Frequently Asked Questions

Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.